St Jude Medical Newswire

St Jude Medical Newswire

Comprehensive Real-Time News Feed for St Jude Medical.

Results 1 - 20 of 13,934 in St Jude Medical

  1. Alere Sues Abbott to Force Completion of $5.8 Billion DealRead the original story

    1 hr ago | The Washington Post

    Alere Inc. sued Abbott Laboratories to compel the completion of their pending $5.8 billion takeover deal, claiming the medical-device maker failed to get U.S. antitrust clearance in an effort to scuttle the contentious transaction. Abbott "has breached the merger agreement between the parties by failing to promptly secure antitrust approvals and other regulatory requirements," Alere said in a filing Friday in Delaware Chancery Court.

    Comment?

  2. Traders Sell St. Jude Medical Inc.Read the original story w/Photo

    3 hrs ago | Daily Political

    Traders sold shares of St. Jude Medical Inc. on strength during trading on Friday. $210.13 million flowed into the stock on the tick-up and $239.81 million flowed out of the stock on the tick-down, for a money net flow of $29.68 million out of the stock.

    Comment?

  3. St. James's Place plc (STJ) to Issue Dividend of GBX 12.33 on September 30thRead the original story w/Photo

    5 hrs ago | Daily Political

    St. James's Place plc announced a dividend on Wednesday, July 27th. Stockholders of record on Thursday, September 1st will be paid a dividend of GBX 12.33 per share on Friday, September 30th.

    Comment?

  4. St. Jude Denies Short Seller's Claims; Abbott Remains CommittedRead the original story

    6 hrs ago | The Washington Post

    St. Jude Medical Inc. said a report issued by short-seller Muddy Waters LLC that could have derailed its purchase by Abbott Laboratories was "false and misleading," while Abbott said it remained committed to the $25 billion deal. "St. Jude Medical stands behind the security and safety of our devices as confirmed by independent third parties and supported through our regulatory submissions," the St. Paul, Minnesota-based company said Friday in a statement.

    Comment?

  5. UPDATE 1-Hong Kong's first Zika case tests negativeRead the original story w/Photo

    7 hrs ago | Reuters

    Aug 27 Hong Kong's first Zika patient tested negative for the virus on Friday and was discharged from hospital, the government said in a statement. On Thursday, the Centre for Health Protection had said the 38-year-old woman, who had reurned to Hong Kong after spending two weeks in in the Caribbean, had tested positive.

    Comment?

  6. St. Jude Denies Claims in Muddy Waters ReportRead the original story

    9 hrs ago | WRKO-AM Brighton

    St. Jude Medical on Friday denied allegations made by a research firm that its pacemakers and other heart devices were vulnerable to hacking and other cybersecurity threats.

    Comment?

  7. U.S. judge will not block California school vaccination lawRead the original story w/Photo

    11 hrs ago | Reuters

    The ruling came in response to a lawsuit by parents and health and education-related nonprofits, challenging the law at the beginning of the first school year in which it was to go into effect. The measure eliminated the so-called personal beliefs and religious exemptions from California's school vaccination law, meaning that only children with a valid medical excuse could forego vaccinations for such childhood diseases as measles and polio.

    Comment?

  8. Whiplashed investors stay skittish about St. JudeRead the original story w/Photo

    11 hrs ago | Reuters

    Aug 26 One day after a short seller claimed that St. Jude Medical Inc's heart implants are vulnerable to deadly cyber attacks, investors appear most concerned about whether the accusation will derail St. Jude's $24 billion planned deal for Abbott Labs to buy it. St. Jude's stock at one point fell around 3 percent on Friday, though it ended the day slightly up, following a drop of around 5 percent on Thursday after Muddy Waters Capital leveled the accusation against St. Jude.

    Comment?

  9. St. Jude Medical Inc. (STJ) Sees Unusually-High Trading VolumeRead the original story w/Photo

    11 hrs ago | Daily Political

    St. Jude Medical Inc. shares saw unusually-high trading volume on Friday . Approximately 6,796,322 shares changed hands during trading, an increase of 89% from the previous session's volume of 3,597,841 shares.The stock last traded at $75.51 and had previously closed at $77.82.

    Comment?

  10. Cybersecurity firms stirs controversy in alleging medical device flawsRead the original story w/Photo

    13 hrs ago | Yahoo!

    In an apparent first, the investment firm Muddy Waters Capital on Thursday relied on cybersecurity research to recommend that investors bet against a major medical device maker's stock. Muddy Waters issued a detailed litany of serious-sounding - but unconfirmed - flaws affecting a range of devices that St. Jude Medical Inc. manufactures.

    Comment?

  11. Media Statement from St. Jude Children's Research HospitalRead the original story w/Photo

    Wednesday Aug 24 | PR Newswire

    Founded by the late entertainer , St. Jude Children's Research Hospital is a nonprofit pediatric cancer research hospital. St. Jude Medical is a publicly traded company.

    Comment?

  12. UPDATE 1-Sycamore Partners, liquidators bid on bankrupt U.S. teen retailer AeropostaleRead the original story w/Photo

    May 14, 2015 | Reuters

    Investment firm Versa Capital Management LLC did not submit a bid for the business, the people said. Versa had been preparing a stalking horse offer for Aeropostale as a going concern business, and the retailer had received court approval to pay some of the expenses incurred by Versa in putting together the proposal.

    Comment?

  13. St. Jude Medical Refutes Muddy Waters Device Security Allegations and ...Read the original story

    12 hrs ago | Information Technology

    St. Jude Medical, Inc. , a global medical device company, today issued the following statement: We have examined the allegations made by Capital and MedSec on August 25, 2016 regarding the safety and security of our pacemakers and defibrillators, and while we would have preferred the opportunity to review a detailed account of the information, based on available information, we conclude that the report is false and misleading. Our top priority is to reassure our patients, caregivers and physicians that our devices are secure and to ensure ongoing access to the proven clinical benefits of remote monitoring.

    Comment?

  14. St. Jude Says Short-Seller's Claims Are False and MisleadingRead the original story

    12 hrs ago | The Washington Post

    St. Jude Medical Inc. denied allegations that its pacemakers and defibrillators are vulnerable to cybersecurity attacks, saying a report issued by short-seller Muddy Waters LLC on Thursday was "false and misleading." "St. Jude Medical stands behind the security and safety of our devices as confirmed by independent third parties and supported through our regulatory submissions," the St. Paul, Minnesota-based company said Friday in a statement.

    Comment?

  15. Alere Sues Abbott to Force Completion of $5.8 Billion DealRead the original story

    12 hrs ago | The Washington Post

    Alere Inc. sued Abbott Laboratories to compel the completion of their pending $5.8 billion takeover deal, claiming the medical-device maker failed to get U.S. antitrust clearance in an effort to scuttle the contentious transaction. Abbott "has breached the merger agreement between the parties by failing to promptly secure antitrust approvals and other regulatory requirements," Alere said in a filing Friday in Delaware Chancery Court.

    Comment?

  16. After-Hours Movers: Benzinga Exclusives Shake StocksRead the original story w/Photo

    13 hrs ago | Benzinga

    U.S. stocks were mixed on Friday trading, with the S&P 500 and Dow indexes closing down, and the Nasdaq slightly up, as speculation around the timing of an interest rate hike mounted following comments from key Federal Reserve officials. Shares of Herbalife Ltd. gained more than 4.1 percent in after-hours trading, after Carl Icahn revealed an additional stake in the stock.

    Comment?

  17. St. Jude Denies Report Heart Devices Are Vulnerable to Cyber AttacksRead the original story w/Photo

    13 hrs ago | Fox News

    St. Jude Medical Inc. on Friday denied allegations made by a research firm that its pacemakers and other heart devices were vulnerable to hacking and other cybersecurity threats. "St. Jude Medical stands behind the security and safety of our devices as confirmed by independent third parties and supported through our regulatory submissions," the company said Friday.

    Comment?

  18. Self-injury is a 'major killer' in U.SRead the original story w/Photo

    13 hrs ago | Reuters

    When deaths from substance abuse are counted as self-inflicted, then deaths from self-injury in the U.S. are tied with deaths attributed to diabetes and outnumber those from flu and pneumonia or kidney disease, new research suggests. "Self injury is a major killer and it encompasses more than suicide," said study leader Ian Rockett, of West Virginia University School of Public Health in Morgantown.

    Comment?

  19. Trading in stock of medical device paused after hackers team with short sellerRead the original story w/Photo

    13 hrs ago | Ars Technica

    Trading in the stock of medical device manufacturer St. Jude Medical was halted Friday afternoon after a dramatic drop in its value. That drop was triggered by news of alleged vulnerabilities in the company's cardiac care devices.

    Comment?

  20. St. Jude says report by short sellers 'false and misleading'Read the original story w/Photo

    14 hrs ago | Reuters

    Aug 26 Medical device manufacturer St. Jude Medical Inc said on Friday that a report by short-selling firm Muddy Waters and a cyber-security researcher alleging its heart devices were riddled with bugs was "false and misleading." The report, which caused St Jude shares to decline after its release on Thursday, alleged there were significant security bugs in the company's [email protected] device for monitoring implanted heart devices.

    Comment?